plus a reduced need for injections into the eye with current therapy Eylea. On the strength of the results, 4DMT is planning to start a phase 3 trial of the gene therapy by the end of the first ...

Ocular Therapeutix (NASDAQ:OCUL) traded higher in the morning hours on Tuesday after Needham initiated its coverage with a Buy rating and a $15 per share target, citing the potential of its lead ...

A second study – KINGFISHER – compared monthly injections with Beovu to Eylea, and found the rate of IOI was a little higher with Novartis drug, at 4% versus 2.9% with Eylea, with most cases ...

sham injection. Unidentified speaker, Analyst: Okay, very good. And I do wanted to say from investor perspective, it seems very easy beta thesis for them to push back for the eye indication with ...

Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in ...

In addition to comparable BCVA levels, the researchers concluded that the PDS implant “provides effective, durable, and ...

With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...

Sabrowski received an anti-inflammatory injection in his elbow Friday, Tom Withers of the Associated Press reports. The injection will cause Sabrowski to sit down for a few days, and the Guardians ...

The slugger will head back to New York on Monday for yet another round of PRP injections on his ailing elbows, a team spokesman said Friday. Stanton had been away since Feb. 24 to deal with a ...

Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease ...

Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic ...